2023-09-012024-08-312024-08-31false14279251LLB ECHOCARDIOGRAPHY LIMITED2025-02-1086101falseiso4217:GBPxbrli:pure142792512023-09-01142792512024-08-31142792512023-09-012024-08-31142792512022-08-05142792512023-08-31142792512022-08-052023-08-3114279251bus:SmallEntities2023-09-012024-08-3114279251bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3114279251bus:FullAccounts2023-09-012024-08-3114279251bus:PrivateLimitedCompanyLtd2023-09-012024-08-3114279251core:WithinOneYear2024-08-3114279251core:AfterOneYear2024-08-3114279251core:WithinOneYear2023-08-3114279251core:AfterOneYear2023-08-3114279251core:ShareCapital2024-08-3114279251core:SharePremium2024-08-3114279251core:RevaluationReserve2024-08-3114279251core:OtherReservesSubtotal2024-08-3114279251core:RetainedEarningsAccumulatedLosses2024-08-3114279251core:ShareCapital2023-08-3114279251core:SharePremium2023-08-3114279251core:RevaluationReserve2023-08-3114279251core:OtherReservesSubtotal2023-08-3114279251core:RetainedEarningsAccumulatedLosses2023-08-3114279251core:LandBuildings2024-08-3114279251core:PlantMachinery2024-08-3114279251core:Vehicles2024-08-3114279251core:FurnitureFittings2024-08-3114279251core:OfficeEquipment2024-08-3114279251core:NetGoodwill2024-08-3114279251core:IntangibleAssetsOtherThanGoodwill2024-08-3114279251core:ListedExchangeTraded2024-08-3114279251core:UnlistedNon-exchangeTraded2024-08-3114279251core:LandBuildings2023-08-3114279251core:PlantMachinery2023-08-3114279251core:Vehicles2023-08-3114279251core:FurnitureFittings2023-08-3114279251core:OfficeEquipment2023-08-3114279251core:NetGoodwill2023-08-3114279251core:IntangibleAssetsOtherThanGoodwill2023-08-3114279251core:ListedExchangeTraded2023-08-3114279251core:UnlistedNon-exchangeTraded2023-08-3114279251core:LandBuildings2023-09-012024-08-3114279251core:PlantMachinery2023-09-012024-08-3114279251core:Vehicles2023-09-012024-08-3114279251core:FurnitureFittings2023-09-012024-08-3114279251core:OfficeEquipment2023-09-012024-08-3114279251core:NetGoodwill2023-09-012024-08-3114279251core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3114279251core:ListedExchangeTraded2023-09-012024-08-3114279251core:UnlistedNon-exchangeTraded2023-09-012024-08-3114279251core:MoreThanFiveYears2023-09-012024-08-3114279251core:Non-currentFinancialInstruments2024-08-3114279251core:Non-currentFinancialInstruments2023-08-3114279251dpl:CostSales2023-09-012024-08-3114279251dpl:DistributionCosts2023-09-012024-08-3114279251core:LandBuildings2023-09-012024-08-3114279251core:PlantMachinery2023-09-012024-08-3114279251core:Vehicles2023-09-012024-08-3114279251core:FurnitureFittings2023-09-012024-08-3114279251core:OfficeEquipment2023-09-012024-08-3114279251dpl:AdministrativeExpenses2023-09-012024-08-3114279251core:NetGoodwill2023-09-012024-08-3114279251core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3114279251dpl:GroupUndertakings2023-09-012024-08-3114279251dpl:ParticipatingInterests2023-09-012024-08-3114279251dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3114279251core:ListedExchangeTraded2023-09-012024-08-3114279251dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3114279251core:UnlistedNon-exchangeTraded2023-09-012024-08-3114279251dpl:CostSales2022-08-052023-08-3114279251dpl:DistributionCosts2022-08-052023-08-3114279251core:LandBuildings2022-08-052023-08-3114279251core:PlantMachinery2022-08-052023-08-3114279251core:Vehicles2022-08-052023-08-3114279251core:FurnitureFittings2022-08-052023-08-3114279251core:OfficeEquipment2022-08-052023-08-3114279251dpl:AdministrativeExpenses2022-08-052023-08-3114279251core:NetGoodwill2022-08-052023-08-3114279251core:IntangibleAssetsOtherThanGoodwill2022-08-052023-08-3114279251dpl:GroupUndertakings2022-08-052023-08-3114279251dpl:ParticipatingInterests2022-08-052023-08-3114279251dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-052023-08-3114279251core:ListedExchangeTraded2022-08-052023-08-3114279251dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-052023-08-3114279251core:UnlistedNon-exchangeTraded2022-08-052023-08-3114279251core:NetGoodwill2024-08-3114279251core:IntangibleAssetsOtherThanGoodwill2024-08-3114279251core:LandBuildings2024-08-3114279251core:PlantMachinery2024-08-3114279251core:Vehicles2024-08-3114279251core:FurnitureFittings2024-08-3114279251core:OfficeEquipment2024-08-3114279251core:AfterOneYear2024-08-3114279251core:WithinOneYear2024-08-3114279251core:ListedExchangeTraded2024-08-3114279251core:UnlistedNon-exchangeTraded2024-08-3114279251core:ShareCapital2024-08-3114279251core:SharePremium2024-08-3114279251core:RevaluationReserve2024-08-3114279251core:OtherReservesSubtotal2024-08-3114279251core:RetainedEarningsAccumulatedLosses2024-08-3114279251core:NetGoodwill2023-08-3114279251core:IntangibleAssetsOtherThanGoodwill2023-08-3114279251core:LandBuildings2023-08-3114279251core:PlantMachinery2023-08-3114279251core:Vehicles2023-08-3114279251core:FurnitureFittings2023-08-3114279251core:OfficeEquipment2023-08-3114279251core:AfterOneYear2023-08-3114279251core:WithinOneYear2023-08-3114279251core:ListedExchangeTraded2023-08-3114279251core:UnlistedNon-exchangeTraded2023-08-3114279251core:ShareCapital2023-08-3114279251core:SharePremium2023-08-3114279251core:RevaluationReserve2023-08-3114279251core:OtherReservesSubtotal2023-08-3114279251core:RetainedEarningsAccumulatedLosses2023-08-3114279251core:NetGoodwill2022-08-0514279251core:IntangibleAssetsOtherThanGoodwill2022-08-0514279251core:LandBuildings2022-08-0514279251core:PlantMachinery2022-08-0514279251core:Vehicles2022-08-0514279251core:FurnitureFittings2022-08-0514279251core:OfficeEquipment2022-08-0514279251core:AfterOneYear2022-08-0514279251core:WithinOneYear2022-08-0514279251core:ListedExchangeTraded2022-08-0514279251core:UnlistedNon-exchangeTraded2022-08-0514279251core:ShareCapital2022-08-0514279251core:SharePremium2022-08-0514279251core:RevaluationReserve2022-08-0514279251core:OtherReservesSubtotal2022-08-0514279251core:RetainedEarningsAccumulatedLosses2022-08-0514279251core:AfterOneYear2023-09-012024-08-3114279251core:WithinOneYear2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3114279251core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3114279251core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3114279251core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3114279251core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3114279251core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3114279251core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3114279251core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3114279251core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3114279251core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3114279251core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3114279251core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3114279251bus:Director12023-09-012024-08-31142792511bus:Director12023-09-01142792511bus:Director12023-09-012024-08-31142792511bus:Director12024-08-31142792512023-09-01142792512023-09-012024-08-31142792512024-08-31

LLB ECHOCARDIOGRAPHY LIMITED

Registered Number
14279251
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

LLB ECHOCARDIOGRAPHY LIMITED
Company Information
for the year from 1 September 2023 to 31 August 2024

Director

LE BAS, Lucinda

Registered Address

C/O Xeinadin First Floor Secure House
Lulworth Close
Chandler's Ford
SO53 3TL

Registered Number

14279251 (England and Wales)
LLB ECHOCARDIOGRAPHY LIMITED
Balance Sheet as at
31 August 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3501641
501641
Current assets
Debtors43,5579,997
Cash at bank and on hand6,0202,567
9,57712,564
Creditors amounts falling due within one year5(9,039)(9,998)
Net current assets (liabilities)5382,566
Total assets less current liabilities1,0393,207
Net assets1,0393,207
Capital and reserves
Called up share capital100100
Profit and loss account9393,107
Shareholders' funds1,0393,207
The financial statements were approved and authorised for issue by the Director on 10 February 2025, and are signed on its behalf by:
LE BAS, Lucinda
Director
Registered Company No. 14279251
LLB ECHOCARDIOGRAPHY LIMITED
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment5
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 September 23699699
At 31 August 24699699
Depreciation and impairment
At 01 September 235858
Charge for year140140
At 31 August 24198198
Net book value
At 31 August 24501501
At 31 August 23641641
4.Debtors: amounts due within one year

2024

2023

££
Amounts owed by associates and joint ventures / participating interests3,5579,997
Total3,5579,997
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security8,0919,140
Accrued liabilities and deferred income948858
Total9,0399,998
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
LE BAS, Lucinda9,99749,02855,4683,557
9,99749,02855,4683,557
Loans between the company and the director are interest free and repayable on demand